PT - JOURNAL ARTICLE AU - M. Brodlie AU - M.C. McKean AU - G.E. Johnson AU - A.E. Anderson AU - C.M.U. Hilkens AU - A.J. Fisher AU - P.A. Corris AU - J.L. Lordan AU - C. Ward TI - Raised interleukin-17 is immuno-localised to neutrophils in cystic fibrosis lung disease AID - 10.1183/09031936.00067110 DP - 2010 Jan 01 TA - European Respiratory Journal PG - erj00671-2010 4099 - http://erj.ersjournals.com/content/early/2010/11/25/09031936.00067110.short 4100 - http://erj.ersjournals.com/content/early/2010/11/25/09031936.00067110.full AB - Interleukin-17 is pivotal in orchestrating the activity of neutrophils. Neutrophilic inflammation is the dominant pathology in cystic fibrosis lung disease. We investigated interleukin-17 protein expression in the lower airway in cystic fibrosis, its cellular immuno-localisation and the effects of interleukin-17 on cystic fibrosis primary bronchial epithelial cells.Immunohistochemistry was performed on explanted cystic fibrosis lungs and compared to the non-suppurative condition pulmonary hypertension. Airway lavages and epithelial cultures were generated from explanted cystic fibrosis lungs.Immunoreactivity for interleukin-17 was significantly increased in the lower airway epithelium in cystic fibrosis (median 14.1%) compared to pulmonary hypertension (2.95%, P=0.0001). The number of cells staining positive for interleukin-17 in the lower airway mucosa was also increased (64 compared to 9/mm basement membrane, P=0.0005) and included both neutrophils in addition to mononuclear cells. Interleukin-17 was detectable in airway lavages from explanted cystic fibrosis lungs. Treatment of epithelial cultures with interleukin-17 increased production of interleukin-8, interleukin-6 and granulocyte macrophage colony-stimulating factor.In conclusion, immunoreactive interleukin-17 is raised in the lower airway of people with cystic fibrosis and localises to both neutrophils and mononuclear cells. Interleukin-17 increases production of pro-neutrophilic mediators by cystic fibrosis epithelial cells, suggesting potential for a positive feedback element in airway inflammation.